Molecular features of TNBC govern heterogeneity in the response to radiation and autophagy inhibition
Abstract Triple negative breast cancer (TNBC) is a heterogeneous and a highly aggressive type of breast cancer. Standard of care for TNBC patients includes surgery, radio-, chemo- and immunotherapy, depending on the stage of the disease. Immunotherapy is ineffective as monotherapy but can be enhance...
Saved in:
| Main Authors: | Patrick Fischer, Maximilian Schmid, Anna Ohradanova-Repic, Rebecca Schneeweiss, Jana Hadatsch, Odysseus Grünert, Johannes Benedum, Anna Röhrer, Felix Staudinger, Philipp Schatzlmaier, Niccolo Bragato, Sandra Barna, Magdalena Engl, Ava Kleinwächter, Dietmar Georg, Joachim Widder, Sylvia Kerschbaum-Gruber, Dea Slade |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2025-07-01
|
| Series: | Cell Death and Disease |
| Online Access: | https://doi.org/10.1038/s41419-025-07873-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PARP7 as a new target for activating anti-tumor immunity in cancer
by: Katerina Popova, et al.
Published: (2025-03-01) -
Retrospective Analysis of Transcriptomic Differences between Triple-Negative Breast Cancer (TNBC) and non-TNBC
by: Çağlar Berkel
Published: (2024-05-01) -
The search for a TNBC vaccine: the guardian vaccine
by: Cory Fines, et al.
Published: (2025-12-01) -
PIBF1 expression and survival outcome in TNBC and Non-TNBC breast cancer patients with lymph node metastasis who undertaken chemotherapy
by: Eunju Shin, et al.
Published: (2025-08-01) -
Inflammation-associated drug resistance and tumor growth in TNBC
by: Arij Fouzat Hassan, et al.
Published: (2025-08-01)